(PAHC) Phibro Animal Health - Performance 53.1% in 12m
PAHC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
10.69%
#52 in Peer-Group
Rel. Strength
85.89%
#1047 in Stock-Universe
Total Return 12m
53.07%
#20 in Peer-Group
Total Return 5y
12.28%
#55 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 31.5 |
| P/E Forward | 10.6 |
| High / Low | USD |
|---|---|
| 52 Week High | 25.96 USD |
| 52 Week Low | 16.05 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 82.54 |
| Buy/Sell Signal +-5 | -0.15 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PAHC (53.1%) vs XLV (-5.4%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.4% | 125% | 327% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
3.69% | 17.7% | 78.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
4.34% | -14.2% | 404% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NOVN SW Novartis |
1.15% | 2.99% | 49.2% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-7.83% | 4.46% | 46.4% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-6.3% | -5% | 110% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| AZN NASDAQ AstraZeneca |
-2.85% | -8.53% | 45.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
-1.19% | -10.7% | 41.1% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: PAHC vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for PAHC
| Total Return (including Dividends) | PAHC | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 4.42% | 2.04% | 4.55% |
| 3 Months | 20.16% | -7.24% | 10.78% |
| 12 Months | 53.07% | -5.41% | 14.71% |
| 5 Years | 12.28% | 43.58% | 112.53% |
| Trend Score (consistency of price movement) | PAHC | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 59.1% | 34.5% | 79.2% |
| 3 Months | 84.1% | -46.5% | 92.9% |
| 12 Months | 46.6% | -71.8% | 44.2% |
| 5 Years | -7.8% | 87.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th69.07 | 2.33% | -0.12% |
| 3 Month | %th74.23 | 29.55% | 8.47% |
| 12 Month | %th90.21 | 61.84% | 33.45% |
| 5 Years | %th70.10 | -21.81% | -47.17% |
FAQs
Does Phibro Animal Health (PAHC) outperform the market?
Yes,
over the last 12 months PAHC made 53.07%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.41%.
Over the last 3 months PAHC made 20.16%, while XLV made -7.24%.
Performance Comparison PAHC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PAHC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.5% | -0.1% | 16.8% | 38% |
| US NASDAQ 100 | QQQ | 0.7% | -1.1% | 14.6% | 38% |
| German DAX 40 | DAX | 1.6% | 4.4% | 3.8% | 23% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.8% | 0.3% | 18.8% | 35% |
| Hongkong Hang Seng | HSI | 1.9% | -1.4% | 1% | 18% |
| India NIFTY 50 | INDA | 1.9% | 2.3% | 17.1% | 53% |
| Brasil Bovespa | EWZ | 0.1% | -3.4% | -7.7% | 40% |
PAHC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0% | -2.3% | 10.1% | 24% |
| Consumer Discretionary | XLY | 3.1% | 2.8% | 25.5% | 33% |
| Consumer Staples | XLP | 5% | 6.1% | 18.6% | 44% |
| Energy | XLE | 5.8% | 0.9% | 22.2% | 57% |
| Financial | XLF | 1.4% | 1.3% | 13.7% | 24% |
| Health Care | XLV | 2.4% | 2.4% | 24% | 58% |
| Industrial | XLI | 1.9% | 0.7% | 10.2% | 29% |
| Materials | XLB | 3.4% | 2.8% | 17.4% | 50% |
| Real Estate | XLRE | 5.9% | 4.4% | 19.4% | 41% |
| Technology | XLK | 0.2% | -4.5% | 13.6% | 41% |
| Utilities | XLU | 3.9% | 4.4% | 13.4% | 29% |
| Aerospace & Defense | XAR | -0.5% | -5.5% | -4.6% | 0% |
| Biotech | XBI | 3.6% | 2.3% | 30.7% | 64% |
| Homebuilder | XHB | 3.2% | -1.7% | 28.1% | 52% |
| Retail | XRT | 4.6% | 3% | 25.5% | 47% |
PAHC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 8.7% | -0.70% | 26.1% | 63% |
| Natural Gas | UNG | 13.7% | 13.9% | 31.9% | 61% |
| Gold | GLD | 6.4% | 6.6% | -3.1% | 12% |
| Silver | SLV | 4.9% | 0.6% | -1.8% | 31% |
| Copper | CPER | 1.2% | 0.2% | -2.9% | 38% |
PAHC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.7% | 0.8% | 20% | 51% |
| iShares High Yield Corp. Bond | HYG | 3.5% | 2.6% | 17.8% | 42% |